Prospective Randomized Controlled Treatment Trial for Chronic Central Serous Chorioretinopathy (PLACE)
A Prospective Randomized Controlled Multicentre Trial Comparing Half-dose Photodynamic Therapy (PDT) With High-density Subthreshold Micropulse Laser Treatment in Patients With Chronic Central Serous Chorioretinopathy (CSC)
Sponsor: Leiden University Medical Center
This PHASE4 trial investigates Chronic Central Serous Chorioretinopathy and is currently completed. Leiden University Medical Center leads this study, which shows 7 recorded versions since 2013 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Mar 2022 — Jul 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Mar 2022 [monthly]
Completed PHASE4
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE4
▶ Show 2 earlier versions
-
Oct 2017 — Jun 2018 [monthly]
Completed PHASE4
Status: Recruiting → Completed
-
Jan 2017 — Oct 2017 [monthly]
Recruiting PHASE4
First recorded
Dec 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Leiden University Medical Center
- Radboud University Medical Center
- University Hospital, Paris
- University of Cologne
- University of Oxford
For direct contact, visit the study record on ClinicalTrials.gov .